跳至主要内容
临床试验/NCT06569316
NCT06569316招募中不适用

Journey to Understanding - American Indian Peoples Engagement in Cancer Research Arizona (JUNIPER)

Mayo Clinic2 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2024年9月27日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
Mayo Clinic
入组人数
300
试验地点
2
主要终点
Successful accrual of Indigenous American (IA) participants

研究概览

简要总结

This clinical trial is studying the genetic changes in cells associated with different types of cancer in American Indian (AI) populations in the Southwest to improve cancer screening, precision prevention, and therapeutic intervention for individual in these communities. AI tribes have much lower rates of cancer screening, have more limited access to healthcare, are more often diagnosed at later stages of disease, and have the poorest outcomes in all types of cancer when compared to any other racial and ethnic group in the United States. Due to these significant cancer health disparities, AIs have been understudied and little is known about the molecular characterization of tumors arising in AIs. Undergoing genetic testing of tumors may improve cancer outcomes in AI participants and communities.

详细描述

PRIMARY OBJECTIVES:

I. To develop culturally appropriate, respectful, trusted, and collaborative means to engage and recruit American Indians (AIs) affected by cancer (newly diagnosed cancer participants, participants undergoing cancer treatment, and cancer survivors) for molecular characterization of their tumors.

Ia. Conduct direct participant engagement with cancer participants/survivors, community advisors, and partners to refine and optimize methods/processes.

Ib. Identify, recruit, and consent eligible AI cancer participants/survivors. Ic. Implement tissue acquisition, epidemiologic, behavioral, and clinical data collection, conduct continuous assessment of performance benchmarks.

Id. Return clinical grade and clinically useful genomic data to participants with navigation to counseling and clinical resources as warranted and as they select.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female adults >= 18 years of age
  • Cancer patient undergoing active treatment or a cancer survivor
  • Self-identify as American Indian

排除标准

  • Unable to provide informed consent
  • Individuals who are under 18 years of age
  • Prisoners

研究组 & 干预措施

Screening (blood, saliva, tissue collection, genetic testing)

Experimental

Patients undergo collection of blood or saliva samples on study for genetic testing. Patients also undergo collection of leftover tissue obtained from SOC surgical procedure or biopsy, or stored tissue samples for genetic testing as well as mouthwash saliva samples on study. Patients receive the results of their genetic testing and are given resources for counseling and further care.

干预措施: Communication Intervention (Other)

Screening (blood, saliva, tissue collection, genetic testing)

Experimental

Patients undergo collection of blood or saliva samples on study for genetic testing. Patients also undergo collection of leftover tissue obtained from SOC surgical procedure or biopsy, or stored tissue samples for genetic testing as well as mouthwash saliva samples on study. Patients receive the results of their genetic testing and are given resources for counseling and further care.

干预措施: Genetic Testing (Other)

Screening (blood, saliva, tissue collection, genetic testing)

Experimental

Patients undergo collection of blood or saliva samples on study for genetic testing. Patients also undergo collection of leftover tissue obtained from SOC surgical procedure or biopsy, or stored tissue samples for genetic testing as well as mouthwash saliva samples on study. Patients receive the results of their genetic testing and are given resources for counseling and further care.

干预措施: Biospecimen Collection (Procedure)

Screening (blood, saliva, tissue collection, genetic testing)

Experimental

Patients undergo collection of blood or saliva samples on study for genetic testing. Patients also undergo collection of leftover tissue obtained from SOC surgical procedure or biopsy, or stored tissue samples for genetic testing as well as mouthwash saliva samples on study. Patients receive the results of their genetic testing and are given resources for counseling and further care.

干预措施: Survey Administration (Other)

结局指标

主要结局

Successful accrual of Indigenous American (IA) participants

时间窗: Up to 5 years

Assessed by the number of IA participants consented to study.

Return of valuable genetic results to participants

时间窗: Up to 5 years

Assessed by the number of participants who receive genetic results. Clinically useful genomic data will be returned to participants with navigation to counseling and clinical resources as warranted and as they select.

Successful accrual of American Indian (AI) participants

时间窗: Up to 5 years

Assessed by the number of AI participants consented to study.

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Genetic Testing for the Prevention of Cancer in... | 临床试验